CoChat

Synthetic LXR agonists increase LDL in CETP species

Open access
Groot, Pieter H.E., Pearce, Nigel J., Yates, John W., Stocker, Claire, Sauermelch, Charles, Doe, Christopher P., Willette, Robert N., Olzinski, Alan, Peters, Tambra, d'Epagnier, Denise, Morasco, Kathleen O., Krawiec, John A., Webb, Christine L., Aravindhan, Karpagam, Jucker, Beat, Burgert, Mark, Ma, Chun, Marino, Joseph P., Collins, Jon L., Macphee, Colin H., Thompson, Scott K., Jaye, Michael · 2005 · Journal of Lipid Research
Cited by 120

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Liver X receptor (LXR) nuclear receptors regulate the expression of genes involved in whole body cholesterol trafficking, including absorption, excretion, catabolism, and cellular efflux, and possess both anti-inflammatory and antidiabetic actions. Accordingly, LXR is considered an appealing drug target for multiple indications. Synthetic LXR agonists demonstrated inhibition of atherosclerosis progression in murine genetic models; however, these and other studies indicated that their major undesired side effect is an increase of plasma and hepatic triglycerides. A significant impediment to extrapolating results with LXR agonists from mouse to humans is the absence in mice of cholesteryl ester transfer protein, a known LXR target gene, and the upregulation in mice but not humans of cholesterol 7alpha-hydroxylase. To better predict the human response to LXR agonism, two synthetic LXR agonists were examined in hamsters and cynomolgus monkeys. In contrast to previously published results in mice, neither LXR agonist increased HDL-cholesterol in hamsters, and similar results were obtained in cynomolgus monkeys. Importantly, in both species, LXR agonists increased LDL-cholesterol, an unfavorable effect not apparent from earlier murine studies. These results reveal additional problems associated with current synthetic LXR agonists and emphasize the importance of profiling compounds in preclinical species with a more human-like LXR response and lipoprotein metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m500116-jlr200

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 120

Metadata

Authors
Groot, P. H. E., Pearce, N. J., Yates, J. W., Stocker, C., Sauermelch, C., Doe, C. P., Willette, R. N., Olzinski, A., Peters, T., d'Epagnier, D., Morasco, K. O., Krawiec, J. A., Webb, C. L., Aravindhan, K., Jucker, B., Burgert, M., Ma, C., Marino, J. P., Collins, J. L., Macphee, C. H., Thompson, S. K., & Jaye, M.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2005-10
Volume
46
Issue
10
Pages
2182-2191
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2130728151
Cited by
120
References
6
FWCI
6.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synthetic LXR agonists increase LDL in CETP species. https://app.cochat.ai/papers/10.1194/jlr.m500116-jlr200
The paper
Groot, P. H. E., Pearce, N. J., Yates, J. W., Stocker, C., Sauermelch, C., Doe, C. P., Willette, R. N., Olzinski, A., Peters, T., d'Epagnier, D., Morasco, K. O., Krawiec, J. A., Webb, C. L., Aravindhan, K., Jucker, B., Burgert, M., Ma, C., Marino, J. P., Collins, J. L., . . . Jaye, M. (2005). Synthetic LXR agonists increase LDL in CETP species. Journal of Lipid Research. https://doi.org/10.1194/jlr.m500116-jlr200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.